Filing Flows › Verastem (VSTM) › Q3 2026 › vs Q2 2026
Verastem (VSTM) Q3 2026 vs Q2 2026 (quarter over quarter)
Verastem's revenue fell $16.1M (-40%) from $40.1M in Q2 2026 to $24.0M in Q3 2026.
Verastem, Q3 2026: revenue $24.0M (+114% year over year), operating margin -313.3%, net loss $74.7M, operating cash flow −$33.6M. The chart draws each line against Q2 2026, the increases inside each band.
Every line
| Line | Q3 2026 | Q2 2026 | Change | % |
|---|---|---|---|---|
| Revenue | $24.0M | $40.1M | −$16.1M | -40% |
| Other income, net | $501K | −$1.1M | $1.6M | — |
| Net loss | $74.7M | $34.7M | $40.0M | +116% |
| Costs & expenses | $99.2M | $74.8M | $24.5M | +33% |
| Operating costs | $99.2M | $72.8M | $26.4M | +36% |
| Research & development | $68.8M | $41.3M | $27.5M | +66% |
| SG&A | $26.5M | $27.4M | −$924K | -3% |
| Other operating costs | $3.9M | $4.0M | −$96K | -2% |
| Operating cash sources | $74.7M | $34.7M | $40.0M | +116% |
| Share-based compensation | $3.7M | $3.4M | $281K | +8% |
| Working capital & other | $37.4M | −$12.7M | $50.1M | — |
| Cash used in operations | $33.6M | $43.9M | −$10.3M | -23% |
| Net loss absorbed | $74.7M | $34.7M | $40.0M | +116% |
Questions
How much did Verastem's revenue grow quarter over quarter in Q3 2026?
Verastem's revenue fell $16.1M (-40%) from $40.1M in Q2 2026 to $24.0M in Q3 2026.